APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vascular Closure Devices (VCDS)

Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.

Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.

Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.

Selected research

Market Outlook & Growth Opportunities

Global Vascular Closure Devices (VCDS) Market Outlook and Growth Opportunities 2026

Report ID 173925720423 December 2025197 pages

Choose your research edition.

Industry ResearchVascular Closure Devices (VCDS) Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Closure Devices (VCDS) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Vascular Closure Devices (VCDS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Closure Devices (VCDS) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Closure Devices (VCDS) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.

Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.

Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.

Read the full market overview

Global Vascular Closure Devices (VCDS) key players include Abbott Laboratories, St. Jude Medical, Cardinal Health, etc.

This report provides an overview of the global Vascular Closure Devices (VCDS) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vascular Closure Devices (VCDS) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vascular Closure Devices (VCDS) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vascular Closure Devices (VCDS) market size, projected growth trends, production technologies, key applications, and end-use industries.

Vascular Closure Devices (VCDS) Segment by Company

Abbott Laboratories

Abbott

Cardinal Health

Morrris Innovative

Vascular Closure Devices (VCDS) Segment by Type

5F-6F

5F-21F

Vascular Closure Devices (VCDS) Segment by Application

Angiography Surgery

Interventional Procedures

Vascular Closure Devices (VCDS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vascular Closure Devices (VCDS) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vascular Closure Devices (VCDS) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vascular Closure Devices (VCDS) significant trends, drivers, influence factors in global and regions.

6. To analyze Vascular Closure Devices (VCDS) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Closure Devices (VCDS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Closure Devices (VCDS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Closure Devices (VCDS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vascular Closure Devices (VCDS) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vascular Closure Devices (VCDS) industry.

Chapter 3: Detailed analysis of Vascular Closure Devices (VCDS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vascular Closure Devices (VCDS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vascular Closure Devices (VCDS) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vascular Closure Devices (VCDS) Industry Trends Table 2. Vascular Closure Devices (VCDS) Industry Drivers Table 3. Vascular Closure Devices (VCDS) Industry Opportunities and Challenges Table 4. Vascular Closure Devices (VCDS) Industry Restraints Table 5. Global Vascular Closure Devices (VCDS) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vascular Closure Devices (VCDS) Revenue Share by Company (2021-2026) Table 7. Global Vascular Closure Devices (VCDS) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Vascular Closure Devices (VCDS) Sales Volume Share by Company (2021-2026) Table 9. Global Vascular Closure Devices (VCDS) Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Vascular Closure Devices (VCDS) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vascular Closure Devices (VCDS) Key Company Manufacturing Base & Headquarters Table 12. Global Vascular Closure Devices (VCDS) Company, Product Type & Application Table 13. Global Vascular Closure Devices (VCDS) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vascular Closure Devices (VCDS) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5F-6F Table 18. Significant Companies of 5F-21F Table 19. Global Vascular Closure Devices (VCDS) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Vascular Closure Devices (VCDS) Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Vascular Closure Devices (VCDS) Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Vascular Closure Devices (VCDS) Sales Volume Share by Type (2021-2026) Table 23. Global Vascular Closure Devices (VCDS) Sales Volume Share by Type (2027-2032) Table 24. Global Vascular Closure Devices (VCDS) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Vascular Closure Devices (VCDS) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Vascular Closure Devices (VCDS) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Vascular Closure Devices (VCDS) Sales Value Share by Type (2021-2026) Table 28. Global Vascular Closure Devices (VCDS) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Angiography Surgery Table 30. Significant Companies of Interventional Procedures Table 31. Global Vascular Closure Devices (VCDS) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Vascular Closure Devices (VCDS) Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Vascular Closure Devices (VCDS) Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Vascular Closure Devices (VCDS) Sales Volume Share by Application (2021-2026) Table 35. Global Vascular Closure Devices (VCDS) Sales Volume Share by Application (2027-2032) Table 36. Global Vascular Closure Devices (VCDS) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Vascular Closure Devices (VCDS) Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Vascular Closure Devices (VCDS) Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Vascular Closure Devices (VCDS) Sales Value Share by Application (2021-2026) Table 40. Global Vascular Closure Devices (VCDS) Sales Value Share by Application (2027-2032) Table 41. Global Vascular Closure Devices (VCDS) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Vascular Closure Devices (VCDS) Sales by Region (2021-2026) & (K Units) Table 43. Global Vascular Closure Devices (VCDS) Sales Market Share by Region (2021-2026) Table 44. Global Vascular Closure Devices (VCDS) Sales by Region (2027-2032) & (K Units) Table 45. Global Vascular Closure Devices (VCDS) Sales Market Share by Region (2027-2032) Table 46. Global Vascular Closure Devices (VCDS) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Vascular Closure Devices (VCDS) Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Vascular Closure Devices (VCDS) Sales Value Share by Region (2021-2026) Table 49. Global Vascular Closure Devices (VCDS) Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Vascular Closure Devices (VCDS) Sales Value Share by Region (2027-2032) Table 51. Global Vascular Closure Devices (VCDS) Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Vascular Closure Devices (VCDS) Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Vascular Closure Devices (VCDS) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Vascular Closure Devices (VCDS) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Vascular Closure Devices (VCDS) Sales by Country (2021-2026) & (K Units) Table 56. Global Vascular Closure Devices (VCDS) Sales Market Share by Country (2021-2026) Table 57. Global Vascular Closure Devices (VCDS) Sales by Country (2027-2032) & (K Units) Table 58. Global Vascular Closure Devices (VCDS) Sales Market Share by Country (2027-2032) Table 59. Global Vascular Closure Devices (VCDS) Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Vascular Closure Devices (VCDS) Sales Value Market Share by Country (2021-2026) Table 61. Global Vascular Closure Devices (VCDS) Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Vascular Closure Devices (VCDS) Sales Value Market Share by Country (2027-2032) Table 63. Abbott Laboratories Company Information Table 64. Abbott Laboratories Business Overview Table 65. Abbott Laboratories Vascular Closure Devices (VCDS) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Abbott Laboratories Vascular Closure Devices (VCDS) Product Portfolio Table 67. Abbott Laboratories Recent Development Table 68. Abbott Company Information Table 69. Abbott Business Overview Table 70. Abbott Vascular Closure Devices (VCDS) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Abbott Vascular Closure Devices (VCDS) Product Portfolio Table 72. Abbott Recent Development Table 73. Cardinal Health Company Information Table 74. Cardinal Health Business Overview Table 75. Cardinal Health Vascular Closure Devices (VCDS) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Cardinal Health Vascular Closure Devices (VCDS) Product Portfolio Table 77. Cardinal Health Recent Development Table 78. Morrris Innovative Company Information Table 79. Morrris Innovative Business Overview Table 80. Morrris Innovative Vascular Closure Devices (VCDS) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Morrris Innovative Vascular Closure Devices (VCDS) Product Portfolio Table 82. Morrris Innovative Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Vascular Closure Devices (VCDS) Distributors List Table 86. Vascular Closure Devices (VCDS) Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Vascular Closure Devices (VCDS) Product Image Figure 2. Global Vascular Closure Devices (VCDS) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vascular Closure Devices (VCDS) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vascular Closure Devices (VCDS) Sales (2021-2032) & (K Units) Figure 5. Global Vascular Closure Devices (VCDS) Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Vascular Closure Devices (VCDS) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5F-6F Image Figure 10. 5F-21F Image Figure 11. Global Vascular Closure Devices (VCDS) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Vascular Closure Devices (VCDS) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Vascular Closure Devices (VCDS) Sales Volume Share by Type (2021-2032) Figure 14. Global Vascular Closure Devices (VCDS) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Vascular Closure Devices (VCDS) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Vascular Closure Devices (VCDS) Sales Value Share by Type (2021-2032) Figure 17. Angiography Surgery Image Figure 18. Interventional Procedures Image Figure 19. Global Vascular Closure Devices (VCDS) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Vascular Closure Devices (VCDS) Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Vascular Closure Devices (VCDS) Sales Volume Share by Application (2021-2032) Figure 22. Global Vascular Closure Devices (VCDS) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Vascular Closure Devices (VCDS) Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Vascular Closure Devices (VCDS) Sales Value Share by Application (2021-2032) Figure 25. Global Vascular Closure Devices (VCDS) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Vascular Closure Devices (VCDS) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Vascular Closure Devices (VCDS) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Vascular Closure Devices (VCDS) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Vascular Closure Devices (VCDS) Sales Value (2021-2032) & (US$ Million) Figure 30. North America Vascular Closure Devices (VCDS) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Vascular Closure Devices (VCDS) Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Vascular Closure Devices (VCDS) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Vascular Closure Devices (VCDS) Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Vascular Closure Devices (VCDS) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Vascular Closure Devices (VCDS) Sales Value (2021-2032) & (US$ Million) Figure 36. South America Vascular Closure Devices (VCDS) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Vascular Closure Devices (VCDS) Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Vascular Closure Devices (VCDS) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Vascular Closure Devices (VCDS) Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Vascular Closure Devices (VCDS) Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 5F-6F
  • 5F-21F
Applications
  • Angiography Surgery
  • Interventional Procedures
Companies covered
  • Abbott Laboratories
  • Abbott
  • Cardinal Health
  • Morrris Innovative

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vascular Closure Devices (VCDS) Sales Value (2021-2032)
  4. 1.2.2 Global Vascular Closure Devices (VCDS) Sales Volume (2021-2032)
  5. 1.2.3 Global Vascular Closure Devices (VCDS) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vascular Closure Devices (VCDS) Market Dynamics
  1. 2.1 Vascular Closure Devices (VCDS) Industry Trends
  2. 2.2 Vascular Closure Devices (VCDS) Industry Drivers
  3. 2.3 Vascular Closure Devices (VCDS) Industry Opportunities and Challenges
  4. 2.4 Vascular Closure Devices (VCDS) Industry Restraints
3 Vascular Closure Devices (VCDS) Market by Company
  1. 3.1 Global Vascular Closure Devices (VCDS) Company Revenue Ranking in 2025
  2. 3.2 Global Vascular Closure Devices (VCDS) Revenue by Company (2021-2026)
  3. 3.3 Global Vascular Closure Devices (VCDS) Sales Volume by Company (2021-2026)
  4. 3.4 Global Vascular Closure Devices (VCDS) Average Price by Company (2021-2026)
  5. 3.5 Global Vascular Closure Devices (VCDS) Company Ranking (2024-2026)
  6. 3.6 Global Vascular Closure Devices (VCDS) Company Manufacturing Base and Headquarters
  7. 3.7 Global Vascular Closure Devices (VCDS) Company Product Type and Application
  8. 3.8 Global Vascular Closure Devices (VCDS) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vascular Closure Devices (VCDS) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vascular Closure Devices (VCDS) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vascular Closure Devices (VCDS) Market by Type
  1. 4.1 Vascular Closure Devices (VCDS) Type Introduction
  2. 4.1.1 5F-6F
  3. 4.1.2 5F-21F
  4. 4.2 Global Vascular Closure Devices (VCDS) Sales Volume by Type
  5. 4.2.1 Global Vascular Closure Devices (VCDS) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vascular Closure Devices (VCDS) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Vascular Closure Devices (VCDS) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Vascular Closure Devices (VCDS) Sales Value by Type
  9. 4.3.1 Global Vascular Closure Devices (VCDS) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Vascular Closure Devices (VCDS) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Vascular Closure Devices (VCDS) Sales Value Share by Type (2021-2032)
5 Vascular Closure Devices (VCDS) Market by Application
  1. 5.1 Vascular Closure Devices (VCDS) Application Introduction
  2. 5.1.1 Angiography Surgery
  3. 5.1.2 Interventional Procedures
  4. 5.2 Global Vascular Closure Devices (VCDS) Sales Volume by Application
  5. 5.2.1 Global Vascular Closure Devices (VCDS) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Vascular Closure Devices (VCDS) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Vascular Closure Devices (VCDS) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Vascular Closure Devices (VCDS) Sales Value by Application
  9. 5.3.1 Global Vascular Closure Devices (VCDS) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Vascular Closure Devices (VCDS) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Vascular Closure Devices (VCDS) Sales Value Share by Application (2021-2032)
6 Vascular Closure Devices (VCDS) Regional Sales and Value Analysis
  1. 6.1 Global Vascular Closure Devices (VCDS) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vascular Closure Devices (VCDS) Sales by Region (2021-2032)
  3. 6.2.1 Global Vascular Closure Devices (VCDS) Sales by Region: 2021-2026
  4. 6.2.2 Global Vascular Closure Devices (VCDS) Sales by Region (2027-2032)
  5. 6.3 Global Vascular Closure Devices (VCDS) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vascular Closure Devices (VCDS) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vascular Closure Devices (VCDS) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vascular Closure Devices (VCDS) Sales Value by Region (2027-2032)
  9. 6.5 Global Vascular Closure Devices (VCDS) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vascular Closure Devices (VCDS) Sales Value (2021-2032)
  12. 6.6.2 North America Vascular Closure Devices (VCDS) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vascular Closure Devices (VCDS) Sales Value (2021-2032)
  15. 6.7.2 Europe Vascular Closure Devices (VCDS) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vascular Closure Devices (VCDS) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vascular Closure Devices (VCDS) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vascular Closure Devices (VCDS) Sales Value (2021-2032)
  21. 6.9.2 South America Vascular Closure Devices (VCDS) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vascular Closure Devices (VCDS) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vascular Closure Devices (VCDS) Sales Value Share by Country, 2025 VS 2032
7 Vascular Closure Devices (VCDS) Country-level Sales and Value Analysis
  1. 7.1 Global Vascular Closure Devices (VCDS) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vascular Closure Devices (VCDS) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vascular Closure Devices (VCDS) Sales by Country (2021-2032)
  4. 7.3.1 Global Vascular Closure Devices (VCDS) Sales by Country (2021-2026)
  5. 7.3.2 Global Vascular Closure Devices (VCDS) Sales by Country (2027-2032)
  6. 7.4 Global Vascular Closure Devices (VCDS) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vascular Closure Devices (VCDS) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vascular Closure Devices (VCDS) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vascular Closure Devices (VCDS) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vascular Closure Devices (VCDS) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vascular Closure Devices (VCDS) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Vascular Closure Devices (VCDS) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Vascular Closure Devices (VCDS) Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Vascular Closure Devices (VCDS) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Vascular Closure Devices (VCDS) Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Cardinal Health
  14. 8.3.1 Cardinal Health Company Information
  15. 8.3.2 Cardinal Health Business Overview
  16. 8.3.3 Cardinal Health Vascular Closure Devices (VCDS) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cardinal Health Vascular Closure Devices (VCDS) Product Portfolio
  18. 8.3.5 Cardinal Health Recent Developments
  19. 8.4 Morrris Innovative
  20. 8.4.1 Morrris Innovative Company Information
  21. 8.4.2 Morrris Innovative Business Overview
  22. 8.4.3 Morrris Innovative Vascular Closure Devices (VCDS) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Morrris Innovative Vascular Closure Devices (VCDS) Product Portfolio
  24. 8.4.5 Morrris Innovative Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vascular Closure Devices (VCDS) Value Chain Analysis
  2. 9.1.1 Vascular Closure Devices (VCDS) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vascular Closure Devices (VCDS) Sales Mode & Process
  6. 9.2 Vascular Closure Devices (VCDS) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vascular Closure Devices (VCDS) Distributors
  9. 9.2.3 Vascular Closure Devices (VCDS) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst